Articles published in
Int J Radiat Oncol Biol Phys
Retrieve available abstracts of 87 articles: HTML format
Single Articles
July 2025
PATEL RK, Lee J, Patel M, Zaorsky NG, et al Evolution of Image Guidance and Adaptive Radiation Therapy for Localized Prostate
Cancer.
Int J Radiat Oncol Biol Phys. 2025;122:968-975. PubMedAbstract available
KEALL PJ, El Naqa I, Fast MF, Hewson EA, et al Real-Time Dose-Guided Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2025;122:787-801. PubMedAbstract available
SNYDER JE, Fast MF, Uijtewaal P, Borman PTS, et al Enhancing Delivery Efficiency on the Magnetic Resonance-Linac: A Comprehensive
Evaluation of Prostate Stereotactic Body Radiation Therapy Using Volumetric
Modulated Arc Therapy.
Int J Radiat Oncol Biol Phys. 2025;122:976-985. PubMedAbstract available
PATEL KR, Mena E, Rowe LS, Ning H, et al A Phase 1 Trial of Image Guided Risk Volume-Adapted Postprostatectomy Radiation
Therapy.
Int J Radiat Oncol Biol Phys. 2025;122:986-994. PubMedAbstract available
HOWARD TP, Ferguson D, Han Z, Mamon HJ, et al Magnetic Resonance-Guided Stereotactic Body Radiation Therapy With Daily Online
Plan Adaptation for Reirradiation in the Abdomen.
Int J Radiat Oncol Biol Phys. 2025;122:752-759. PubMedAbstract available
VAN WERKHOVEN LA, Milder MTW, Hoogeman MS, van Werkhoven E, et al Results of a Single-Arm Phase 2 Clinical Trial: Online Adaptive Stereotactic Body
Radiation Therapy for Abdominal-Pelvic Oligometastases.
Int J Radiat Oncol Biol Phys. 2025;122:729-738. PubMedAbstract available
June 2025
COURTNEY PT, Dong H, Lao Y, Pham J, et al Dosimetric Comparison of MRI-Guided Versus Reduced Margin CT-Guided Stereotactic
Body Radiotherapy for Localized Prostate Cancer: Post-Hoc Analysis of a Phase III
Trial.
Int J Radiat Oncol Biol Phys. 2025 Jun 5:S0360-3016(25)00553. PubMedAbstract available
DICKSTEIN DR, Kapouranis T, Sigel K, Wheldon CW, et al Sexual Health Outcomes in Sexual Minority and Heterosexual Men After Prostate
Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2025;122:416-423. PubMedAbstract available
May 2025
GOULET M, Duguay-Drouin P, Mascolo-Fortin J, Megroureche J, et al Clinical Application of Deep Learning-Assisted Needles Reconstruction in Prostate
Ultrasound Brachytherapy.
Int J Radiat Oncol Biol Phys. 2025;122:199-207. PubMedAbstract available
April 2025
CROOK J, Cheng JC, Arbour G, Araujo C, et al A Randomized Comparison of High Dose Rate and Low Dose Rate Prostate
Brachytherapy Combined with External Beam Radiotherapy for Unfavourable Prostate
Cancer: Efficacy Results after Median Follow-up 74 Months.
Int J Radiat Oncol Biol Phys. 2025 Apr 3:S0360-3016(25)00303. PubMedAbstract available
MAITRE P, Zaorsky NG, Dess RT, Koontz BF, et al Precision Over Tradition: Transforming Prostate Cancer Treatment with
Stereotactic Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2025;121:1093-1097. PubMed
CHEN J, Yang Y, Feng H, Zhang L, et al Robust Optimization for Spot-Scanning Proton Therapy based on
Dose-Linear-Energy-Transfer Volume Constraints.
Int J Radiat Oncol Biol Phys. 2025;121:1303-1315. PubMedAbstract available
March 2025
PATEL P, Dreibe S, Attard G, Cole A, et al Stereotactic body radiotherapy for oligoprogressive disease in androgen
suppressed prostate cancer: Primary endpoint analysis of the TRAP trial.
Int J Radiat Oncol Biol Phys. 2025 Mar 9:S0360-3016(25)00225. PubMedAbstract available
VENKATESULU BP, Adams W, Joel R, Ross D, et al The Importance of Multi-parametric MRI, PET/CT, and Biopsy for Identifying and
Delineating the Extent of Intraprostatic Radiorecurrent Prostate Cancer: A
Secondary Analysis of the F-SHARP Clinical Trial.
Int J Radiat Oncol Biol Phys. 2025 Mar 6:S0360-3016(25)00193. PubMedAbstract available
MONINGI S, Orio PF 3rd An Aggressive Approach for Mucinous Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2025;121:584. PubMed
REARDON MD, Bibby BAS, Thiruthaneeswaran N, Pereira RR, et al Hypoxia-Associated Gene Signatures Are Not Prognostic in High-Risk Localized
Prostate Cancers Undergoing Androgen Deprivation Therapy With Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2025;121:752-760. PubMedAbstract available
BROOKS FMD, Glenn MC, Hernandez V, Saez J, et al Is the Imaging Radiation Oncology Core Head and Neck Credentialing Phantom an
Effective Surrogate for Different Anatomic Sites?
Int J Radiat Oncol Biol Phys. 2025;121:811-821. PubMedAbstract available
FENG H, Shan J, Vargas CE, Keole SR, et al Online Adaptive Proton Therapy Facilitated by Artificial Intelligence-Based
Autosegmentation in Pencil Beam Scanning Proton Therapy.
Int J Radiat Oncol Biol Phys. 2025;121:822-831. PubMedAbstract available
LE REUN E, Espenel S, Garcia MA, Girbovan AH, et al Image-Guided Brachytherapy for Pediatric Bladder and/or Prostate
Rhabdomyosarcoma: Toward an Increased Personalization of Treatment.
Int J Radiat Oncol Biol Phys. 2025;121:658-666. PubMedAbstract available
February 2025
TWARD J, Lloyd S, Johnson S, Dechet C, et al A Phase 2 Trial of Radium(223) and Stereotactic Ablative Radiotherapy in
Hormone-Naive Men with Oligometastatic Prostate Cancer to Bone: The RadSABR
study.
Int J Radiat Oncol Biol Phys. 2025 Feb 6:S0360-3016(25)00095. PubMedAbstract available
PATEL KR, Spratt DE, Tran PT, Krauss DJ, et al The Benefit of Short-Term Androgen Deprivation Therapy with Radiotherapy for
Intermediate-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2025 Feb 6:S0360-3016(25)00086. PubMedAbstract available
LANGE M, Campion L, Ollivier L, Renouf M, et al Patterns of relapse following radiotherapy of intermediate-risk (IR) prostate
cancer (PCa) on the PROFIT randomized trial.
Int J Radiat Oncol Biol Phys. 2025 Feb 4:S0360-3016(25)00089. PubMedAbstract available
ZAMBOGLOU C, Arcangeli S, Kamran SC Stereotactic Body Radiation Therapy for Prostate Cancer is Getting Mature:
10-Year Outcomes From 3 Prospective Trials.
Int J Radiat Oncol Biol Phys. 2025;121:331-332. PubMed
January 2025
PATEL KR, Pra AD, Huang EP, Singh SA, et al The Determinants of Toxicity in the Treatment of Prostate Cancer with a Focal,
Intraprostatic "Microboost".
Int J Radiat Oncol Biol Phys. 2025 Jan 22:S0360-3016(25)00054. PubMedAbstract available
MURTHY V, Mallick I, Maitre P, Mulye G, et al Pelvic regional control with 25Gy in 5 fractions in SBRT for high risk prostate
cancer: Pooled prospective outcomes from the SHARP consortium.
Int J Radiat Oncol Biol Phys. 2025 Jan 2:S0360-3016(24)03773. PubMedAbstract available
ZHANG P, Happersett L, Burleson S, Oh JH, et al Reduction of Postradiation Therapy Urinary Toxicity Via Intrafractional
Megavoltage-Kilovoltage Prostate Location Monitoring.
Int J Radiat Oncol Biol Phys. 2025;121:261-268. PubMedAbstract available
RAJENDRAN P, Chen Y, Qiu L, Niedermayr T, et al Autodelineation of Treatment Target Volume for Radiation Therapy Using Large
Language Model-Aided Multimodal Learning.
Int J Radiat Oncol Biol Phys. 2025;121:230-240. PubMedAbstract available
December 2024
CHOO R, Corbin K, Merrell K, Stish B, et al Five-year outcomes of moderately hypofractionated proton therapy incorporating
elective pelvic nodal irradiation for high-risk prostate cancer.
Int J Radiat Oncol Biol Phys. 2024 Dec 11:S0360-3016(24)03722. PubMedAbstract available
SONG D, Dabkowski M, Costa P, Nurani R, et al Prospective, Randomized Controlled Pivotal Trial of Biodegradable Balloon Rectal
Spacer for Prostate Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2024;120:1410-1420. PubMedAbstract available
ARCANGELI S, Chissotti C, Ferrario F, Lucchini R, et al Ablative Radiation Therapy for Unfavorable Prostate Tumors (ABRUPT): Preliminary
Analysis of Toxicity and Quality of Life from a Prospective Study.
Int J Radiat Oncol Biol Phys. 2024;120:1394-1403. PubMedAbstract available
November 2024
FRANCOLINI G, Di Cataldo V, Garlatti P, Simontacchi G, et al Androgen Deprivation Therapy in Intermediate Prostate Cancer Treated With
Radiation Therapy: The Wide Heterogeneity and Complexity of an Apparently Simple
Situation.
Int J Radiat Oncol Biol Phys. 2024;120:1008-1010. PubMed
SINGH M, Maitre P, Krishnan A, Adsul K, et al Late Urinary Toxicity After Extreme or Moderate Hypofractionated Prostate
Radiation Therapy in Patients With Prior Transurethral Resection of Prostate.
Int J Radiat Oncol Biol Phys. 2024;120:1011-1020. PubMedAbstract available
FUKUOKAYA W, Miki K, Aoki M, Takahashi H, et al Ten-year outcomes of a phase III, multicenter, randomized controlled trial
(SHIP0804) with three-month neoadjuvant androgen deprivation prior to (125)I-seed
transperineal prostate brachytherapy followed by nil versus nine-month adjuvant
hormonal thera
Int J Radiat Oncol Biol Phys. 2024 Nov 15:S0360-3016(24)03584. PubMedAbstract available
OST P, Mottet N PSMA PET-CT, When Seeing Becomes Improving.
Int J Radiat Oncol Biol Phys. 2024;120:646-647. PubMed
MURPHY DG, Emmett L PSMA PET Staging is Advised for All High-Risk Patients With Localized Prostate
Cancer.
Int J Radiat Oncol Biol Phys. 2024;120:642-645. PubMed
MANNAR D, Liu W When Seeds Fail: Local Recurrence of Prostate Cancer Within a Seminal Vesicle
After Brachytherapy.
Int J Radiat Oncol Biol Phys. 2024;120:621-623. PubMed
September 2024
WISDOM AJ, Yeap BY, Michalski JM, Horick NK, et al Setting the Stage: Feasibility and Baseline Characteristics in the PARTIQoL Trial
Comparing Proton Therapy vs. IMRT for Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2024 Sep 26:S0360-3016(24)03444. PubMedAbstract available
MORGAN KM, Deshler LN, Tibbs MD, Qiao EM, et al Prostate Specific Antigen and Prostate Cancer in Gender Affirming Hormone Therapy
for Transgender or Nonbinary Individuals.
Int J Radiat Oncol Biol Phys. 2024 Sep 25:S0360-3016(24)03409. PubMedAbstract available
KENNEDY TAC, Ong WL, Quon H, Cheung P, et al Stereotactic radiotherapy for localized prostate cancer: 10-year outcomes from
three prospective trials.
Int J Radiat Oncol Biol Phys. 2024 Sep 16:S0360-3016(24)03368. PubMedAbstract available
UDOVICICH C, Jia AY, Loblaw A, Eapen R, et al Evolving Paradigms in Prostate Cancer: The Integral Role of PSMA PET/CT in
Primary Staging and Therapeutic Decision-Making.
Int J Radiat Oncol Biol Phys. 2024 Sep 13:S0360-3016(24)03387. PubMedAbstract available
DESAI NB, Nagar H Point: Rectal Spacer Use is Recommended for All Prostate Cancer Radiation Therapy
Fractionation Regimens.
Int J Radiat Oncol Biol Phys. 2024;120:33-35. PubMed
CROOK J, Moideen N, Arbour G, Castro F, et al A Randomized Trial Comparing Quality of Life After Low-Dose Rate or High-Dose
Rate Prostate Brachytherapy Boost With Pelvic External Beam Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2024;120:59-68. PubMedAbstract available
August 2024
ODEN J, Eriksson K, Pavoni B, Crezee H, et al A Novel Framework for Thermoradiotherapy Treatment Planning.
Int J Radiat Oncol Biol Phys. 2024;119:1530-1544. PubMedAbstract available
July 2024
ROY S, MacRae R, Grimes S, Malone J, et al Helical Tomotherapy versus Three-Dimensional Conformal Radiotherapy in High Risk
Prostate Cancer: A Phase III Randomized Controlled Trial.
Int J Radiat Oncol Biol Phys. 2024 Jul 13:S0360-3016(24)02957. PubMedAbstract available
FREDMAN E, Moore A, Icht O, Tschernichovsky R, et al Acute toxicity and early PSA response after two-fraction stereotactic
radiotherapy for localized prostate cancer using peri-rectal spacing - Initial
report of the SABR-Dual trial.
Int J Radiat Oncol Biol Phys. 2024 Jul 11:S0360-3016(24)02947. PubMedAbstract available
TOESCA DAS, Hartsell WF, DeWees TA, Chang JH, et al Stereotactic Body Proton Therapy Versus Conventionally Fractionated Proton
Therapy for Early Prostate Cancer: A Randomized, Controlled, Phase 3 Trial.
Int J Radiat Oncol Biol Phys. 2024 Jul 5:S0360-3016(24)00669. PubMedAbstract available
NIKITAS J, Ong WL, Carrier N, Romero T, et al Prostate-Specific Antigen Response to Androgen Deprivation Therapy in the
Neoadjuvant Setting for High-Risk Prostate Adenocarcinoma (PIRANHA): Pooled
Analysis of Two Randomized Clinical Trials.
Int J Radiat Oncol Biol Phys. 2024;119:826-831. PubMedAbstract available
ONG WL, Nikitas J, Joseph D, Steigler A, et al Long-Term Quality-of-Life Outcomes After Prostate Radiation Therapy With or
Without High-Dose-Rate Brachytherapy Boost: Post Hoc Analysis of TROG 03.04
RADAR.
Int J Radiat Oncol Biol Phys. 2024;119:813-825. PubMedAbstract available
June 2024
ZHONG AY, Lui AJ, Kuznetsova S, Kallis K, et al Clinical Impact of Contouring Variability for Prostate Cancer Tumor Boost.
Int J Radiat Oncol Biol Phys. 2024 Jun 24:S0360-3016(24)00740. PubMedAbstract available
DYKSTRA M, Regan S, Yin H, McLaughlin P, et al Variation in Androgen Deprivation Therapy Use Among Men with Intermediate Risk
Prostate Cancer: Results from a Statewide Radiation Oncology Quality Consortium.
Int J Radiat Oncol Biol Phys. 2024 Jun 4:S0360-3016(24)00689. PubMedAbstract available
WESTERHOFF JM, Lalmahomed TA, Meijers L, Henke L, et al Patient reported outcomes following MR-guided radiotherapy for prostate cancer: a
systematic review and meta-analysis.
Int J Radiat Oncol Biol Phys. 2024 Jun 3:S0360-3016(24)00691. PubMedAbstract available
May 2024
ALEXANDER GS, Krc RF, Assif JW, Sun K, et al Conditional Risk and Predictive Factors Associated with Late Toxicity for
Prostate Cancer Patients Treated with External Beam Radiotherapy Alone on
Randomized Trial RTOG 0126.
Int J Radiat Oncol Biol Phys. 2024 May 31:S0360-3016(24)00686. PubMedAbstract available
GLOWA C, Bendinger AL, Euler-Lange R, Peschke P, et al Irradiation with carbon ions effectively counteracts hypoxia-related
radioresistance in a rat prostate carcinoma.
Int J Radiat Oncol Biol Phys. 2024 May 13:S0360-3016(24)00627. PubMedAbstract available
ALEXANDER A, Gagne I, Bahl G, Kim D, et al Late Toxicity of Prostate Ultrahypofractionated Radiation Therapy Compared With
Moderate Hypofractionation in a Randomized Trial.
Int J Radiat Oncol Biol Phys. 2024;119:110-118. PubMedAbstract available
SUN Y, Tsai Y, Wood R, Shen B, et al KDM3B Single-Nucleotide Polymorphisms Impact Radiation Therapy Toxicity Through
Circular RNA-Mediated KDM3B Expression and Inflammatory Responses.
Int J Radiat Oncol Biol Phys. 2024;119:251-260. PubMedAbstract available
ROY S, Malone S, Sun Y, Zaorsky NG, et al Effect of Pelvic External Beam Radiation Therapy on Bone Mineral Density: A
Secondary Analysis of a Phase 3 Randomized Controlled Trial.
Int J Radiat Oncol Biol Phys. 2024;119:119-126. PubMedAbstract available
April 2024
BAKER S, Lechner L, Liu M, Chang JS, et al Upfront Versus Delayed Systemic Therapy in Patients With Oligometastatic Cancer
Treated With SABR in the Phase 2 SABR-5 Trial.
Int J Radiat Oncol Biol Phys. 2024;118:1497-1506. PubMedAbstract available
MERCIER C, Billiet C, Ost P, Joye I, et al Long-Term Results of a Phase 1 Dose Escalation Trial of Ablative Stereotactic
Body Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2024;118:1490-1496. PubMedAbstract available
LEE K, Lall R, Chopra S, Evans MJ, et al SENTRI: Single-Particle Energy Transducer for Radionuclide Injections for
Personalized Targeted Radionuclide Cancer Therapy.
Int J Radiat Oncol Biol Phys. 2024;118:1575-1584. PubMedAbstract available
March 2024
MAITRE P, Maheshwari G, Sarkar J, Singh P, et al Late urinary toxicity and QOL with pelvic radiotherapy for high-risk prostate
cancer: Dose-effect relations in the POP-RT randomized phase III trial.
Int J Radiat Oncol Biol Phys. 2024 Mar 27:S0360-3016(24)00439. PubMedAbstract available
YASAR B, Suh YE, Chapman E, Nicholls L, et al Simultaneous focal boost with stereotactic radiotherapy for localised
intermediate to high-risk prostate cancer: Primary outcomes of the SPARC phase II
trial.
Int J Radiat Oncol Biol Phys. 2024 Mar 16:S0360-3016(24)00425. PubMedAbstract available
NEILSEN BK, Ma TM, Akingbemi WO, Neylon J, et al Impact of Interfractional Bladder and Trigone Displacement and Deformation on
Radiation Exposure and Subsequent Acute Genitourinary Toxicity: A Post Hoc
Analysis of Patients Treated with Magnetic Resonance Imaging-Guided Prostate
Stereotactic Body Rad
Int J Radiat Oncol Biol Phys. 2024;118:986-997. PubMedAbstract available
WESTLEY RL, Biscombe K, Dunlop A, Mitchell A, et al Interim Toxicity Analysis From the Randomized HERMES Trial of 2- and 5-Fraction
Magnetic Resonance Imaging-Guided Adaptive Prostate Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2024;118:682-687. PubMedAbstract available
STAAL FHE, Janssen J, Oprea-Lager DE, Engelen AM, et al Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed
Tomography-Based Clinical Target Volume Delineation Guideline for
Postprostatectomy Salvage Radiation Therapy: The PERYTON Guideline.
Int J Radiat Oncol Biol Phys. 2024;118:688-696. PubMedAbstract available
February 2024
PATEL KR, Rydzewski NR, Schott E, Cooley-Zgela T, et al A Phase I Trial of Salvage Stereotactic Body Radiation Therapy for Radiorecurrent
Prostate Cancer After Brachytherapy.
Int J Radiat Oncol Biol Phys. 2024 Feb 28:S0360-3016(24)00323. PubMedAbstract available
BESUGLOW J, Tessonnier T, Mein S, Eichkorn T, et al Understanding RBE and clinical outcome of prostate cancer therapy using particle
irradiation: analysis of tumor control probability with mMKM.
Int J Radiat Oncol Biol Phys. 2024 Feb 27:S0360-3016(24)00331. PubMedAbstract available
KING MT, Orio PF, D'Amico AV Can Extreme Dose Escalation With External Beam Radiation Therapy and
Low-Dose-Rate Brachytherapy Boost Obviate the Need for Long-Term Androgen
Deprivation Therapy in Patients With High-Risk Localized Prostate Cancer?
Int J Radiat Oncol Biol Phys. 2024;118:402-403. PubMed
January 2024
TAM A, Li YR Ignorance is Bliss? A Case of Incidental Discovery of ATM Mutation in Prostate
Cancer.
Int J Radiat Oncol Biol Phys. 2024;118:8-9. PubMed
MORGAN SC, Hu C, Dess RT A New Pos-SIB-ility for Prostate and Pelvic Nodal Radiation Therapy in High-Risk
Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2024;118:63-65. PubMed
TSUI JMG, Kehayias CE, Leeman JE, Nguyen PL, et al Assessing the Feasibility of Using Artificial Intelligence-Segmented Dominant
Intraprostatic Lesion for Focal Intraprostatic Boost With External Beam Radiation
Therapy.
Int J Radiat Oncol Biol Phys. 2024;118:74-84. PubMedAbstract available
December 2023
CHOUDHURY M, Thomas SS, Cain A, Palvai S, et al Timing of High-Dose Rate Brachytherapy with External Beam Radiotherapy in
intermediate and high-risk localised Prostate Cancer (THEPCA): a randomised
trial.
Int J Radiat Oncol Biol Phys. 2023 Dec 30:S0360-3016(23)08137. PubMedAbstract available
NEYLON J, Ma TM, Savjani R, Low DA, et al Quantifying Intrafraction Motion and the Impact of Gating for MRI-guided
Stereotactic Radiotherapy for Prostate Cancer: Analysis of the MRI arm from the
MIRAGE Phase III Randomized Trial.
Int J Radiat Oncol Biol Phys. 2023 Dec 29:S0360-3016(23)08309. PubMedAbstract available
ACHARD V, Zilli T, Lamanna G, Jorcano S, et al Urethra-sparing prostate cancer stereotactic body radiotherapy: sexual function
and radiation dose to the penile bulb, the crura, and the internal pudendal
arteries from a randomized phase 2 trial.
Int J Radiat Oncol Biol Phys. 2023 Dec 29:S0360-3016(23)08307. PubMedAbstract available
PATEL TA, Jain B, Vapiwala N, Chino F, et al Trends in Utilization and Medicare Spending on Short-Course Radiotherapy for
Breast and Prostate Cancer: An Episode-Based Analysis from 2015-2019.
Int J Radiat Oncol Biol Phys. 2023 Dec 8:S0360-3016(23)08173. PubMedAbstract available
MENDEZ LC, Crook J, Martell K, Schaly B, et al Is ultra-hypofractionated whole pelvis radiotherapy (WPRT) as well tolerated as
conventionally fractionated WPRT in prostate cancer patients? Early results from
the HOPE Trial.
Int J Radiat Oncol Biol Phys. 2023 Dec 8:S0360-3016(23)08189. PubMedAbstract available
LUI AJ, Kallis K, Zhong AY, Hussain TS, et al ReIGNITE Radiation Therapy Boost: A Prospective, International Study of Radiation
Oncologists' Accuracy in Contouring Prostate Tumors for Focal Radiation Therapy
Boost on Conventional Magnetic Resonance Imaging Alone or With Assistance of
Restriction
Int J Radiat Oncol Biol Phys. 2023;117:1145-1152. PubMedAbstract available
BRAND DH, Bruningk SC, Wilkins A, Naismith O, et al Gastrointestinal Toxicity Prediction Not Influenced by Rectal Contour or
Dose-Volume Histogram Definition.
Int J Radiat Oncol Biol Phys. 2023;117:1163-1173. PubMedAbstract available
KYAW JYA, Rendall A, Gillespie EF, Roques T, et al Systematic Review and Meta-analysis of the Association Between Radiation Therapy
Treatment Volume and Patient Outcomes.
Int J Radiat Oncol Biol Phys. 2023;117:1063-1086. PubMedAbstract available
November 2023
GLICKSMAN RM, Loblaw A, Morton G, Vesprini D, et al Randomized trial of concomitant hypofractionated IMRT boost versus conventional
fractionated IMRT boost for localized high-risk prostate cancer (pHART2-RCT).
Int J Radiat Oncol Biol Phys. 2023 Nov 16:S0360-3016(23)08131. PubMedAbstract available
LIU G, Zhao L, Li X, Zhang S, et al A Novel Ultrahigh-Dose-Rate Proton Therapy Technology: Spot-Scanning Proton Arc
Therapy + FLASH (SPLASH).
Int J Radiat Oncol Biol Phys. 2023;117:730-737. PubMedAbstract available
PETERSEN PM, Cook AD, Sydes MR, Clarke N, et al Salvage Radiation Therapy After Radical Prostatectomy: Analysis of Toxicity by
Dose-Fractionation in the RADICALS-RT Trial.
Int J Radiat Oncol Biol Phys. 2023;117:624-629. PubMedAbstract available
October 2023
FINK CA, Wegener D, Sauer LD, Lentz-Hommertgen A, et al Pelvic irradiation for node-positive prostate cancer after prostatectomy:
Long-term results of the prospective PLATIN-4 and PLATIN-5 trials.
Int J Radiat Oncol Biol Phys. 2023 Oct 18:S0360-3016(23)08012. PubMedAbstract available
MOHAMAD O, Zamboglou C, Zilli T, Murthy V, et al Safety of ultra-hypofractionated pelvic nodal irradiation in the definitive
management of prostate cancer: Systematic Review and Meta-analysis.
Int J Radiat Oncol Biol Phys. 2023 Oct 18:S0360-3016(23)08006. PubMedAbstract available
SHAHEEN H, Roach M 3rd, Salans MA, Mohamad O, et al Age 70 +/- 5 Years and Cancer Specific Outcomes after Treatment of Localized
Prostate Cancer: A Systematic Review.
Int J Radiat Oncol Biol Phys. 2023 Oct 1:S0360-3016(23)07930. PubMedAbstract available
September 2023
MENNE GURICOVA K, Groen V, Pos F, Monninkhof E, et al Risk Modeling for Individualization of the FLAME Focal Boost Approach in External
Beam Radiation Therapy for Patients With Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2023 Sep 18:S0360-3016(23)07732. PubMedAbstract available
LI HZ, Qi X, Gao XS, Li XM, et al Dose-Intensified Postoperative Radiation Therapy for Prostate Cancer: Long-term
Results from the PKUFH Randomized Phase III Trial.
Int J Radiat Oncol Biol Phys. 2023 Sep 15:S0360-3016(23)07922. PubMedAbstract available
August 2023
YOROZU A, Namiki M, Saito S, Egawa S, et al Tri-modality Therapy with Iodine-125 Brachytherapy, External Beam Radiation
Therapy, and Short- or Long-Term Androgen Deprivation Therapy for High-Risk
Localized Prostate Cancer: Results of a Multicenter, Randomized Phase 3 Trial
(TRIP/TRIGU0907).
Int J Radiat Oncol Biol Phys. 2023 Aug 24:S0360-3016(23)07843. PubMedAbstract available